Skip to main content
. 2022 Oct 4;12:1031094. doi: 10.3389/fonc.2022.1031094

Table 1.

Cohort description and PD-L1 immunohistochemistry.

n total = 83 Median (range)
OS (days) 107 (44-170)
Age (years) 70 (29-93)
N (%)
Sex male 45 (54%)
female 38 (46%)
Other metastases with 28 (54%)
without 24 (46%)
Chemo before diagnosis yes 22 (39%)
no 34 (61%)
PD-L1 E1L3N high 17 (21%)
low 65 (79%)
PD-L1 SP263 high 16 (20%)
low 65 (80%)

OS, overall survival; CI, confidence interval.